Immuron Ltd ADR (IMRN) - Net Assets
Based on the latest financial reports, Immuron Ltd ADR (IMRN) has net assets worth $8.03 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.09 Million) and total liabilities ($2.06 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Immuron Ltd ADR liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $8.03 Million |
| % of Total Assets | 79.58% |
| Annual Growth Rate | 0.3% |
| 5-Year Change | -68.98% |
| 10-Year Change | 62.57% |
| Growth Volatility | 959.24 |
Immuron Ltd ADR - Net Assets Trend (2001–2025)
This chart illustrates how Immuron Ltd ADR's net assets have evolved over time, based on quarterly financial data. Also explore Immuron Ltd ADR asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Immuron Ltd ADR (2001–2025)
The table below shows the annual net assets of Immuron Ltd ADR from 2001 to 2025. For live valuation and market cap data, see IMRN market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $8.03 Million | -36.80% |
| 2024-06-30 | $12.71 Million | -35.21% |
| 2023-06-30 | $19.62 Million | -15.36% |
| 2022-06-30 | $23.18 Million | -10.49% |
| 2021-06-30 | $25.90 Million | +358.81% |
| 2020-06-30 | $5.64 Million | -23.22% |
| 2019-06-30 | $7.35 Million | -12.89% |
| 2018-06-30 | $8.44 Million | +28.36% |
| 2017-06-30 | $6.57 Million | +33.08% |
| 2016-06-30 | $4.94 Million | +2.70% |
| 2015-06-30 | $4.81 Million | -29.12% |
| 2014-06-30 | $6.79 Million | +4581.10% |
| 2013-06-30 | $144.99K | -92.93% |
| 2012-06-30 | $2.05 Million | +18.33% |
| 2011-06-30 | $1.73 Million | -48.49% |
| 2010-06-30 | $3.36 Million | +1919.26% |
| 2009-06-30 | $-184.87K | -116.65% |
| 2008-06-30 | $1.11 Million | -44.05% |
| 2007-06-30 | $1.98 Million | -62.12% |
| 2006-06-30 | $5.24 Million | -24.77% |
| 2005-06-30 | $6.96 Million | +70.75% |
| 2004-06-30 | $4.08 Million | -35.50% |
| 2002-06-30 | $6.32 Million | -15.41% |
| 2001-06-30 | $7.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Immuron Ltd ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7791043800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $88.87 Million | 1106.51% |
| Other Comprehensive Income | $1.64 Million | 20.41% |
| Total Equity | $8.03 Million | 100.00% |
Immuron Ltd ADR Competitors by Market Cap
The table below lists competitors of Immuron Ltd ADR ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BAWAT WATER TECHNOLOGIES
F:M5W
|
$6.45 Million |
|
Biomerica Inc
NASDAQ:BMRA
|
$6.46 Million |
|
Rolling Optics Holding AB (publ)
ST:RO
|
$6.46 Million |
|
Gencell Ltd
TA:GNCL
|
$6.46 Million |
|
Sewon E&C
KO:091090
|
$6.45 Million |
|
AHB Holdings Bhd
KLSE:7315
|
$6.44 Million |
|
Diriteks Dirilis Tekstil Sanayi ve Ticaret AS
IS:DIRIT
|
$6.44 Million |
|
Ansal Properties & Infrastructure Limited
NSE:ANSALAPI
|
$6.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Immuron Ltd ADR's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,709,444 to 8,031,833, a change of -4,677,611 (-36.8%).
- Net loss of 5,215,987 reduced equity.
- New share issuances of 396,827 increased equity.
- Other comprehensive income decreased equity by 1,534,293.
- Other factors increased equity by 1,675,842.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.22 Million | -64.94% |
| Share Issuances | $396.83K | +4.94% |
| Other Comprehensive Income | $-1.53 Million | -19.1% |
| Other Changes | $1.68 Million | +20.87% |
| Total Change | $- | -36.80% |
Book Value vs Market Value Analysis
This analysis compares Immuron Ltd ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.63x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.63x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-06-30 | $109.05 | $0.88 | x |
| 2002-06-30 | $86.01 | $0.88 | x |
| 2004-06-30 | $55.04 | $0.88 | x |
| 2005-06-30 | $84.03 | $0.88 | x |
| 2006-06-30 | $61.93 | $0.88 | x |
| 2007-06-30 | $21.68 | $0.88 | x |
| 2008-06-30 | $11.45 | $0.88 | x |
| 2009-06-30 | $-1.50 | $0.88 | x |
| 2010-06-30 | $14.19 | $0.88 | x |
| 2011-06-30 | $6.09 | $0.88 | x |
| 2012-06-30 | $6.60 | $0.88 | x |
| 2013-06-30 | $0.45 | $0.88 | x |
| 2014-06-30 | $6.47 | $0.88 | x |
| 2015-06-30 | $2.57 | $0.88 | x |
| 2016-06-30 | $2.59 | $0.88 | x |
| 2017-06-30 | $2.48 | $0.88 | x |
| 2018-06-30 | $2.53 | $0.88 | x |
| 2019-06-30 | $2.03 | $0.88 | x |
| 2020-06-30 | $1.28 | $0.88 | x |
| 2021-06-30 | $4.69 | $0.88 | x |
| 2022-06-30 | $4.07 | $0.88 | x |
| 2023-06-30 | $3.44 | $0.88 | x |
| 2024-06-30 | $2.23 | $0.88 | x |
| 2025-06-30 | $1.39 | $0.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Immuron Ltd ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -64.94%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -71.58%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 1.26x
- Recent ROE (-64.94%) is above the historical average (-168.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -20.89% | -318.19% | 0.06x | 1.05x | $-2.30 Million |
| 2002 | -27.63% | -85.74% | 0.30x | 1.07x | $-2.31 Million |
| 2004 | -28.83% | -31.60% | 0.75x | 1.22x | $-1.57 Million |
| 2005 | -19.21% | -27.39% | 0.60x | 1.16x | $-2.03 Million |
| 2006 | -68.74% | -88.95% | 0.60x | 1.28x | $-4.08 Million |
| 2007 | -170.86% | -77.22% | 1.29x | 1.72x | $-3.47 Million |
| 2008 | -262.88% | -975.86% | 0.15x | 1.75x | $-2.97 Million |
| 2009 | 0.00% | -442.24% | 1.06x | 0.00x | $-2.30 Million |
| 2010 | -56.66% | -412.61% | 0.12x | 1.13x | $-2.24 Million |
| 2011 | -149.80% | -1212.98% | 0.08x | 1.54x | $-2.77 Million |
| 2012 | -112.08% | -511.68% | 0.12x | 1.77x | $-2.50 Million |
| 2013 | -2441.01% | -2363.27% | 0.06x | 17.43x | $-3.55 Million |
| 2014 | -39.66% | -268.54% | 0.13x | 1.12x | $-3.37 Million |
| 2015 | -55.96% | -268.54% | 0.17x | 1.25x | $-3.17 Million |
| 2016 | -143.08% | -706.12% | 0.11x | 1.79x | $-7.56 Million |
| 2017 | -103.49% | -487.33% | 0.17x | 1.26x | $-7.46 Million |
| 2018 | -35.68% | -163.38% | 0.20x | 1.10x | $-3.85 Million |
| 2019 | -63.34% | -195.04% | 0.28x | 1.16x | $-5.39 Million |
| 2020 | -51.47% | -115.33% | 0.41x | 1.10x | $-3.47 Million |
| 2021 | -32.38% | -5751.61% | 0.01x | 1.04x | $-10.97 Million |
| 2022 | -12.31% | -373.01% | 0.03x | 1.07x | $-5.17 Million |
| 2023 | -19.30% | -209.81% | 0.08x | 1.12x | $-5.75 Million |
| 2024 | -54.58% | -141.49% | 0.32x | 1.22x | $-8.21 Million |
| 2025 | -64.94% | -71.58% | 0.72x | 1.26x | $-6.02 Million |
Industry Comparison
This section compares Immuron Ltd ADR's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $44,828,400
- Average return on equity (ROE) among peers: -124.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Immuron Ltd ADR (IMRN) | $8.03 Million | -20.89% | 0.26x | $6.45 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-54.64 Million | 0.00% | 0.00x | $118.88 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $1.07 Billion |
| Abeona Therapeutics Inc (ABEO) | $3.60 Million | -91.89% | 0.28x | $292.09 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $266.97 Million | -19.62% | 0.16x | $171.87 Million |
| Abpro Holdings, Inc. (ABP) | $3.07 Million | -479.81% | 1.57x | $448.19K |
| Absci Corp (ABSI) | $67.00 Million | -21.42% | 0.32x | $345.85 Million |
| Arbutus Biopharma Corp (ABUS) | $88.00 Million | -44.09% | 0.34x | $840.56 Million |
| ABVC Biopharma Inc (ABVC) | $80.00K | -31.70% | 0.38x | $26.41 Million |
| Abivax SA American Depositary Shares (ABVX) | $40.58 Million | -434.26% | 4.06x | $9.33 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $23.36 Million | -97.44% | 0.37x | $3.74 Billion |
About Immuron Ltd ADR
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal d… Read more